Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02040259 · ClinicalTrials.gov registry record
Trevo® Retriever Registry Post Market Surveillance
A clinical trial, sponsored by Stryker Neurovascular.
- Completed
- Registry status
- 2,008
- Enrollment target
NCT02040259 is a clinical trial that has completed, run by Stryker Neurovascular. The registered enrollment target is 2,008 participants.
The verdict
NCT02040259 has completed, sponsored by Stryker Neurovascular.
- COMPLETED
- Registry status
- 2,008 participants
- Enrollment target
Study Summary
The purpose of the Trevo® Retriever Registry is to collect real world performance data of the Trevo Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,008 participants |
| Start Date | 2013-11-25 |
| Est. Completion | 2017-12-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02040259
The ClinicalTrials.gov registry entry for NCT02040259 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,008 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Neurovascular, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02040259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02040259 about?
NCT02040259 is a clinical study titled "Trevo® Retriever Registry Post Market Surveillance". The purpose of the Trevo® Retriever Registry is to collect real world performance data of the Trevo Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.
What is the current status of trial NCT02040259?
This trial is currently completed. The enrollment target is 2,008 participants. The study started on 2013-11-25. Estimated completion is 2017-12-28.
Who is sponsoring clinical trial NCT02040259?
This trial is sponsored by Stryker Neurovascular, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.